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Abstract
Aims To investigate the relationships between age at diagnosis of diabetes, age at diabetic eye screening and severity of
diabetic retinopathy at first and subsequent screenings in children aged 12 or 13 years.
Methods Data were extracted from four English screening programmes and from the Scottish, Welsh and Northern
Irish programmes on all children with diabetes invited for their first and subsequent screening episodes from the age of
12 years. Retinopathy levels at first and subsequent screens, time from diagnosis of diabetes to first screening and age at
diagnosis in years were calculated.
Results Data were available for 2125 children with diabetes screened for the first time at age 12 or 13 years. In those
diagnosed with diabetes at 2 years of age or less, the proportion with retinopathy in one or both eyes was 20% and 11%,
respectively, decreasing to 8% and 2% in those diagnosed between 2 and 12 years (P < 0.0001). Only three children
(aged 8, 10 and 11 years at diagnosis of diabetes) had images graded with referable retinopathy and, of these, two had
non-referable diabetic retinopathy at all subsequent screenings. Of 1703 children with subsequent images, 25 were
graded with referable diabetic retinopathy over a mean follow-up of 3.1 years, an incidence rate of 4.7 (95% confidence
interval, 3.1–7.0) per 1000 per year.
Conclusions In this large cohort of children, the low prevalence and incidence rates of referable diabetic retinopathy
suggest that screening earlier than age 12 is not necessary.
Diabet. Med. 33, 1655–1658 (2016)
Introduction
Screening for diabetic retinopathy is a highly cost-effective
health initiative and blindness caused by diabetes is lower in
populations where a diabetic eye screening programme is
established [1–3].
There is a global increase in the incidence of Type 1 diabetes
mellitus in children [4], particularly in those aged under
5 years [5]. Young children face long pre-pubertal years of
hyperglycaemia, with pre-pubertal, pubertal and post-pub-
ertal years contributing [6,7] to an increased risk of develop-
ment of microvascular complications of diabetic retinopathy.
In 2013–2014, it was reported [8] that there were 26 687
young persons under 25 with diabetes in England and Wales.
Annual screening for diabetic retinopathy is recommended
in England, Scotland, Wales and Northern Ireland for all
those with diabetes aged 12 and above. This was a pragmatic
policy decision taken in 2002–2003 because the youngest
person reported with sight-threatening diabetic retinopathy
in the literature at that time was aged 11.3 years [9].
We report on the relationships between age at diagnosis of
diabetes, diabetic retinopathy levels at first screen at either 12
or 13 years of age, and time to development of sight-
threatening diabetic retinopathy after first screen.
Methods
We recruited data for the Four Nations study [10] from seven
diabetic retinopathy screening programmes: the whole-nation
programmes inWales, Scotland andNorthern Ireland and four
local English programmes (Brighton, Derbyshire, Leeds and
Staffordshire). For the present study, one English programme
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was excluded because no data were available for age at
diagnosis of diabetes. Data for all children referred to the eye
screening programme, grading results at first screen, and age in
years at diagnosis of diabeteswere extracted from the screening
programme databases. The inclusion criteria were all children
aged 12 and 13 years, who attended their first annual digital
photographic screening in theUK.There are very fewexclusion
criteria, such as when a child is terminally ill.
In the English NHS Diabetic Eye Screening Programme all
images are allocated a retinopathy (R) grade and a macu-
lopathy (M) grade on the basis of the absence, presence and
severity of features of diabetic retinopathy found during
quality-assured grading of the retinal images. A mapping
exercise was undertaken between the English, Scottish and
ETDRS Grading Criteria [10–12]. Referable or sight-
threatening diabetic retinopathy was identified by the pres-
ence of features of moderate to severe non-proliferative,
proliferative diabetic retinopathy or maculopathy in at least
one eye. Children with images of either or both eyes that
could not be assessed were excluded from these analyses.
Time from diagnosis of diabetes to first screening and age at
diagnosis were calculated. Screening data from both eyes were
combined to provide four possible categories of children:
 no diabetic retinopathy (R1M0) in both eyes;
 mild non-proliferative diabetic retinopathy (R1M0) in one
eye;
 mild non-proliferative diabetic retinopathy (R1M0) in
both eyes;
 referable diabetic retinopathy (R2 or M1) or fast-track
proliferative diabetic retinopathy (R3) – the referable
diabetic retinopathy group including the fast-track prolif-
erative diabetic retinopathy is referred to as sight-
threatening diabetic retinopathy in this article.
For survival analyses of time to diabetic retinopathy in
children who had at least two retinal screenings, follow-up
was censored at the time of second screening. We estimated
binomial confidence intervals for diabetic retinopathy inci-
dence rates. Kaplan–Meier survival curves of time to diabetic
retinopathy were plotted, stratified by duration of diabetic
retinopathy at first screening. Cox proportional hazards
models estimated the hazard ratio for diabetic retinopathy in
children by duration of diabetes at first screening.
Results
In total, 2125 children received their first screening at the age
of 12 or 13 years. The results of the baseline screen of 2125
children at the age of 12 or 13 years are shown in Table 1.
This has been categorized according to the age of diagnosis
of diabetes. O the children diagnosed under the age of
2 years, 20.1% had signs of any retinopathy compared with
6.3% of those diagnosed at the age of 10 years.
Three children were reported as having referable retinopa-
thy at first screening.
1. The first was diagnosed with diabetes at the age of 8 years
in 2000, first screened in November 2005 at age 13 years,
and approximately annually thereafter until 2012. Refer-
able diabetic retinopathy was recorded at the first screen-
ing, followed by referable diabetic retinopathy in 2007,
2009, 2011 and 2012 with possible pre-proliferative
changes (R2), but mild non-proliferative diabetic retinopa-
thy (NPDR) in both eyes in 2008.
2. The second was diagnosed with diabetes at the age of
10 years in 2004, and first screened in November 2007
and again in 2012. Referable retinopathy (maculopathy –
a blot haemorrhage or exudate < 1 disc diameter from the
foveal centre) was reported in 2007, but only mild NPDR
in one eye was found in 2012.
3. The thirdwas diagnosedwith diabetes at the age of 11 years
in 2005, and screened in 2006, 2009, 2010 and 2011. The
screening result in 2006 reported ‘proliferative retinopathy’
but subsequent screening reported no diabetic retinopathy
in 2009 and mild NPDR in one eye in 2010 and 2011.
Follow-up data were available for 1703 children who had
baseline gradable images and at least one subsequent set of
images. Of these 1703 children, the median age at diagnosis of
diabetes was 8 years with an interquartile range (IQR) of 5–
11 years; 52% of these children were male. At baseline, 1531
(89.9%) children were graded as having no retinopathy, 129
(7.6%) were graded as having mild NPDR in one eye and 43
(2.5%) were graded as having mild NPDR in both eyes.
Of the 1703 childrenwith subsequent images, 16 had a valid
screening result at first screen that was not gradable at the
second screen but had at least one subsequent gradable image.
Of the 129 children with mild NPDR in one eye at first screen,
88 (68.2%) were graded as no diabetic retinopathy, 26
(20.2%) as mild NPDR in one eye and 15 (11.6%) as mild
NPDR in both eyes at the second screen. Of the 43 children
with mild NPDR in both eyes at first screen, 18 (41.9%) were
What’s new?
• This is the largest reported study in the literature of
baseline levels of diabetic retinopathy in the age group
12 or 13 years.
• This is the largest reported study showing the rate of
progression of diabetic retinopathy in adolescents.
• Of 2125 children with diabetes screened for the first
time at age 12 or 13 years, three were found to have
referable disease.
• The absence of referable disease in subsequent screens
in two of the children and of pre-proliferative changes
in the third child suggest that it is unlikely that any
treatment is required.
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graded as no diabetic retinopathy, 12 (27.9%) as mild NPDR
in one eye and 13(30.3%) as mild NPDR both eyes at the
second screen (chi-squared for trend = 146, P < 0.0001).
During subsequent follow-up visits, 25 children were
graded as having sight-threatening or referable diabetic
retinopathy, three of whom were graded as having prolifer-
ative diabetic retinopathy. Figure 1 shows the time to sight-
threatening diabetic retinopathy from baseline screen at 12 or
13 years by age of diagnosis of diabetes in these 25 children.
The median time from baseline to sight-threatening diabetic
retinopathy was 3.1 years with an IQR of 1.7–4.1 years.
The results of the Cox proportional hazards model analysis
show that those with longer duration of diabetes at baseline
screening episode at age 12 or 13 years were at higher risk of
progression to referable diabetic retinopathy with a hazard
ratio of 1.36 per year [95% CI (95% CI), 1.20 to 1.53).
Figure S1 shows the time to referable retinopathy from
diagnosis of diabetes.
Conclusion
Since 2002, the UK National Screening Committee, the SIGN
Guideline [13] and the NICE guidelines [14,15] have recom-
mended annual digital photographic screening for all children
over the age of 12 years and adults with diabetes, with
evidence from studies [16,17] demonstrating that one- and
two-field digital photographic screening could show sensitiv-
ities of > 85% against a reference standard of an ophthalmol-
ogists examination or seven-field stereo-photography.
Specificities of 85–95% were also achieved for mydriatic
photography [16,17] and for staged mydriasis [18].
The American Academy of Ophthalmology [19] recom-
mends annual ophthalmic examinations beginning 3–5 years
after the diagnosis of Type 1 diabetes mellitus. The Interna-
tional Diabetes Federation/International Society for Pediatric
and Adolescent Diabetes guideline [20] recommends exam-
ination for diabetic retinopathy in Type 1 diabetes from age
11 years and after two years’ diabetes duration, and from
diagnosis in Type 2 diabetes.
This study provides original evidence supporting the UK
recommendations. It found that, although 10% of children
have some retinopathy at baseline screening at the age of
12–13 years, only three children (0.17%) were graded as
having sight-threatening diabetic retinopathy. Of the three
we identified, it seems likely that none required treatment
because only one case was consistently diagnosed as sight-
threatening and this was pre-proliferative diabetic retinopa-
thy which does not normally require laser treatment. In those
diagnosed with diabetes in early childhood, the rate of
retinopathy was significantly higher than for those diagnosed
later on. The low prevalence and incidence rates in this large
cohort of children suggest that earlier screening for sight-
Table 1 Results of the baseline screen at the age of 12 years or 13 years
Age at diagnosis
of diabetes
Number
(total = 2125)
Number and
proportion
with any diabetic
retinopathy
N/total (%)
Number and proportion
with mild non-proliferative
diabetic retinopathy
in one eye
N/total (%)
Number and proportion
with mild non-proliferative
diabetic retinopathy
in both eyes
N/total (%)
Number and proportion
with fast track
or referable diabetic
retinopathy
N/total (%)
2 or under 164 33/164 (20.1) 15/164 (9.1) 18/164 (11.0) 0/164 (0.0)
3 118 22/118 (18.6) 18/118 (15.3) 4/118 (3.4) 0/118 (0.0)
4 141 21/141 (14.9) 19/141 (13.5) 2/141 (1.4) 0/141 (0.0)
5 130 15/130 (11.5) 10/130 (7.7) 5/130 (3.8) 0 /130 (0.0)
6 149 15/149 (10.1) 10 /149 (6.7) 5 /149 (3.4) 0/149 (0.0)
7 181 21/181 (11.6) 17 /181 (9.4) 4/181 (2.2) 0 /181 (0.0)
8 193 13/193 (6.7) 9/193 (4.7) 3/193 (1.6) 1/193* (0.5)
9 224 21/224 (9.4) 15 /224 (6.7) 6/224 (2.7) 0 /224 (0.0)
10 271 17/271 (6.3) 14/271 (5.2) 2/271 (0.7) 1/271* (0.4)
11 290 20/290 (6.9) 12 /290 (4.1) 7 /290 (2.4) 1/290* (0.3)
12 264 22/264 (8.3) 17/264 (6.4) 5/264 (1.9) 0/264 (0.0)
*Three children were reported as having referable retinopathy at first screening.
FIGURE 1 Time to sight-threatening diabetic retinopathy from baseline
screen at 12 or 13 years by age of diagnosis of diabetes. The lines
represent the age at which a child was diagnosed with diabetes. The
blue line represents children diagnosed with diabetes at 0,1,2,3 or 4
years. The red line represents children diagnosed with diabetes at 5, 6
or 7 years. The green line represents children diagnosed with diabetes
at 8, 9 or 10 years. The purple line represents children diagnosed with
diabetes at 11 or 12 years.
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threatening diabetic retinopathy is not necessary in this age
group. There may be value in detecting diabetic retinopathy
at a mild stage, but only if it could be shown that closer
follow-up in this at-risk group could reduce the progression
rate and the development of complications in these children.
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Supporting Information
Additional Supporting Information may be found in the
online version of this article:
Figure S1. Time to referable retinopathy from diagnosis of
diabetes. DR, diabetic retinopathy.
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